 |
Welcome
SelenoExcell High Selenium Yeast has been standardized with the Division of Cancer Prevention of the National Cancer Institute and is supported by a Clinical Trial Agreement (CTA). As a result of this standardization and resulting CTA, SelenoExcell has been selected as the sole intervention agent in a series of cancer prevention and health related trials. FDA has approved the following claim related to selenium and SelenoExcell: "Selenium may reduce the risk of certain cancers. Some scientific evidence suggests that consumption of selenium may reduce the risk of certain forms of cancer. However, FDA has determined that this evidence is limited and not conclusive.”
Please click on any of the items on the matrix for more information. |
|
|